Atazanavir crystal nephropathy.
Izzedine
Hassane
H
M'rad
Mona Ben
MB
Bardier
Armelle
A
Daudon
Michel
M
Salmon
Dominique
D
D000069446:Atazanavir Sulfate; D002130:Calcium Phosphates; D003460:Crystallization; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced* / Q000821:virology; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*
D002130:Calcium Phosphates; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; C020243:calcium phosphate